Mochi Health describes a virtual care program with provider visits, messaging, and different support options. Its membership and medication prices need to be read together, especially when a promotion highlights only the medication starting price.
This is a public-source review checked on September 23, 2026, not a personal treatment account or service test. CoreAge Rx pays for featured placement on this site; that relationship does not establish a medical ranking between the services.
Ask for the membership cost plus the price of your proposed prescription. Confirm the product and the support included in that particular plan.
Start with the current billing structure
Mochi’s FAQ lists a one-month membership at $79 and longer membership terms with different total charges. It says compounded tirzepatide starts at $90 per month and that medication prices depend on the weekly dose prescribed. Those figures should not be read as a single all-inclusive $90 service.
The simple sum of the advertised one-month membership and starting medication price is $169. That is illustrative arithmetic, not a quote for your treatment, and it does not establish the price of a higher dose or a different plan. Ask for a complete current estimate in writing.
The FAQ states shipping is included in medication prices. Confirm laboratory charges, insurance-related fees, and any optional services separately. Our cost guide explains how to compare the current bill and the next refill without relying on a starting-price banner.
The plan description deserves a close reading
Mochi’s FAQ describes patient support, provider messaging, and a portal for appointments and prescriptions. Its Health + Medication plan describes physician and health-coach video visits; its insurance-dependent Wellness Plus description includes additional nutrition services. Do not assume every advertised support feature is included in every enrollment option.
Ask who provides nutrition support in the plan you are considering, how visits are scheduled, whether there are limits, and what happens between appointments. A general claim about access does not give a measured response time or establish the quality of an individual encounter.
We did not book a visit or test the portal. For questions about meals and function, our protein and strength fieldnote can help you decide what support you want to discuss.
Sources: Mochi Health: Public care and pricing FAQs · Joint clinical advisory on nutrition during GLP-1 therapy
Confirm which prescription is actually proposed
Mochi’s medication directory includes branded and compounded options. The fact that several medicines appear on a site does not tell you which one you will receive, whether insurance will cover it, or whether a clinician will prescribe at all.
If compounded tirzepatide is proposed, ask for the individualized medical reason, formulation, and dispensing pharmacy. FDA does not approve compounded preparations, and its current tirzepatide shortage policy restricts the circumstances around making copies of commercially available products. Read our compounding guide before treating that option as an ordinary generic substitute.
If an approved brand is proposed instead, ask about the exact presentation, its instructions, and the complete out-of-pocket cost. The Zepbound–Mounjaro comparison explains why the product’s labeled purpose matters.
Sources: Mochi Health: Medication directory · FDA: Concerns with unapproved GLP-1 drugs · FDA: GLP-1 supply and compounding policy · Lilly: Zepbound prescribing information · Lilly: Mounjaro prescribing information
Read refund and renewal terms before paying
Mochi’s public refund page says prescription-medication sales are final and that prescription returns are not accepted. That makes the timing of payment, prescription approval, and order processing worth clarifying before purchasing.
Ask how to stop membership renewal, the deadline for doing so, and whether medication ordering is managed separately. Save the terms applicable to your purchase. We do not infer a guaranteed refund from a general satisfaction claim or assume cancellation reverses a prescription already processed.
For a longer prepaid membership, ask what happens if treatment is unsuitable or your circumstances change. A lower average monthly cost can come with a larger initial commitment. The relevant question is the whole agreement, not only the discount.
Sources: Mochi Health: Refunds · Mochi Health: Terms
What this review can help you decide
The public material gives a basis for investigating Mochi’s ongoing-care structure and pricing components. It does not let us independently verify clinical outcomes, each clinician’s suitability for your case, pharmacy performance, or response times.
Our CoreAge–Mochi comparison puts the two public offers beside the questions you still need answered. The LillyDirect review adds a branded-product access route to the research. None is a substitute for a clinical assessment.
Before choosing, use the visit notebook to ask about safety, follow-up, pharmacy identity, and total recurring cost. Clear answers to those questions are more useful than a provider list that declares a universal winner.
Sources: Mochi Health: Public care and pricing FAQs · LillyDirect: Zepbound self-pay options · FDA: Buying medicines from online pharmacies · FDA: Managing medicine benefits and risks
The source shelf
- Mochi Health: Public care and pricing FAQs
Membership, medication and insurance pathways must be distinguished.
- Joint clinical advisory on nutrition during GLP-1 therapy
Joint professional advisory; general nutritional support, not proof of a specific compounded product or a personal meal plan.
- Mochi Health: Medication directory
Product availability must be confirmed with a clinician; a catalog is not a personal prescribing decision.
- FDA: Concerns with unapproved GLP-1 drugs
Compounding, fraudulent labels, dosing errors and the limits of adverse-event reports. Checked September 23, 2026.
- FDA: GLP-1 supply and compounding policy
Shortage resolution and restrictions on essentially copies; availability requires current professional assessment.
- Lilly: Zepbound prescribing information
Current approved-product label, revised August 2026; does not establish equivalence of compounded preparations.
- Lilly: Mounjaro prescribing information
Product-specific diabetes indications and safety information. Not an interchangeable label for compounded tirzepatide.
- Mochi Health: Refunds
Cancellation and refund rules can differ for membership and a processed prescription.
- Mochi Health: Terms
Platform payment and service terms; read with the selected treatment agreement.
- LillyDirect: Zepbound self-pay options
Current prices vary by presentation and prescribed strength; higher-strength promotional pricing has refill timing conditions.
- FDA: Buying medicines from online pharmacies
Checks for prescription requirements, licensing, contact details and pharmacy support.
- FDA: Managing medicine benefits and risks
General questions for clinical decision-making and medication follow-up.
